PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-5.10%
Revenue decline while CRWV shows 23.55% growth. Joel Greenblatt would examine competitive position erosion.
-48.51%
Cost reduction while CRWV shows 19.16% growth. Joel Greenblatt would examine competitive advantage.
10.64%
Gross profit growth below 50% of CRWV's 25.15%. Michael Burry would check for structural issues.
16.58%
Margin expansion exceeding 1.5x CRWV's 1.30%. David Dodd would verify competitive advantages.
-25.73%
R&D reduction while CRWV shows 0.00% growth. Joel Greenblatt would examine competitive risk.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
18.02%
Similar operating expenses growth to CRWV's 17.97%. Walter Schloss would investigate norms.
-12.82%
Total costs reduction while CRWV shows 18.28% growth. Joel Greenblatt would examine advantage.
No Data
No Data available this quarter, please select a different quarter.
-50.00%
D&A reduction while CRWV shows 26.15% growth. Joel Greenblatt would examine efficiency.
-4.10%
EBITDA decline while CRWV shows 33.05% growth. Joel Greenblatt would examine position.
-23.98%
EBITDA margin decline while CRWV shows 7.69% growth. Joel Greenblatt would examine position.
5.31%
Operating income growth below 50% of CRWV's 169.93%. Michael Burry would check for structural issues.
10.96%
Operating margin growth below 50% of CRWV's 156.60%. Michael Burry would check for structural issues.
61.93%
Other expenses growth while CRWV reduces costs. John Neff would investigate differences.
1825.51%
Pre-tax income growth exceeding 1.5x CRWV's 9.63%. David Dodd would verify competitive advantages.
1928.92%
Pre-tax margin growth exceeding 1.5x CRWV's 26.86%. David Dodd would verify competitive advantages.
1730.30%
Tax expense growth above 1.5x CRWV's 3.78%. Michael Burry would check for concerning trends.
1873.85%
Net income growth exceeding 1.5x CRWV's 7.67%. David Dodd would verify competitive advantages.
1979.85%
Net margin growth exceeding 1.5x CRWV's 25.27%. David Dodd would verify competitive advantages.
2300.00%
EPS growth exceeding 1.5x CRWV's 23.08%. David Dodd would verify competitive advantages.
2300.00%
Diluted EPS growth exceeding 1.5x CRWV's 23.08%. David Dodd would verify competitive advantages.
0.33%
Share count reduction exceeding 1.5x CRWV's 20.32%. David Dodd would verify capital allocation.
-0.07%
Diluted share reduction while CRWV shows 20.32% change. Joel Greenblatt would examine strategy.